CoChat

Immunomodulatory activity of argentatins A and B isolated from guayule

Open access
Silva-Nolasco, Aniela M., de la Cruz-Morcillo, Miguel A., García-Martínez, M. Mercedes, Zalacain, Amaya, Gálvez, Beatriz G., Carmona, Manuel · 2024 · PLOS ONE

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Argentatins are secondary metabolites synthesized by guayule (Parthenium argentatum A. Gray) with numerous potential medical applications. In addition to inhibiting insect growth, they are endowed with several pharmacological properties including antimicrobial and antitumorigenic activity. However, their potential as immunomodulators remains unexplored. The aim of the present study was to investigate whether argentatins can modulate the function of the immune system. Human mesenchymal stem cells were treated with argentatins and the production of several anti- and proinflammatory cytokines was evaluated. The effect of argentatins on the polarization of CD4+ T-lymphocytes and macrophages was also assessed. Results demonstrated that argentatins can modulate the production of proinflammatory cytokines and the polarization of cellular phenotypes, including Th2 lymphocytes and M1 macrophages. These findings suggest that argentatins are promising therapeutic agents in autoimmune or allergic diseases, and open new perspectives for the investigation of argentatins in immune response and in the development of more targeted and effective immunomodulatory therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0304713

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Viability of mesenchymal stem cells (MSCs) in response to argentatin A and B. (A) Viability at 24 h, (B) Viability at 48 h. Cell viability was determined by MTT reduction and was compared to the corresponding untreated control (DMSO), which was normalized to 100% cell viability. Error bars represent the standard error of the mean (SEM) of three independent experiments. Two-way ANOVA with Dunnet´s post test was used to determine differences between argentatin A and B treatments compared with control (*p<0.05, **p<0.005).
Fig 1 Viability of mesenchymal stem cells (MSCs) in response to argentatin A and B. (A) Viability at 24 h, (B) Viability at 48 h. Cell viability was determined by MTT reduction and was compared to the corresponding untreated control (DMSO), which was normalized to 100% cell viability. Error bars represent the standard error of the mean (SEM) of three independent experiments. Two-way ANOVA with Dunnet´s post test was used to determine differences between argentatin A and B treatments compared with control (*p<0.05, **p<0.005).CC BY · PubMed Central
Fig 2 Production of anti-inflammatory and proinflammatory mediators in argentatin-stimulated MSCs. Cytokine production by MSCs was evaluated in the absence or presence of stimulation for 24 hours at 50 μM. Error bars represent the standard error of the mean (SEM) of three individual experiments. Two-way ANOVA with Dunnet´s post test was used to determine differences between argentatin A and B treatments compared with control (***p<0.0005).
Fig 2 Production of anti-inflammatory and proinflammatory mediators in argentatin-stimulated MSCs. Cytokine production by MSCs was evaluated in the absence or presence of stimulation for 24 hours at 50 μM. Error bars represent the standard error of the mean (SEM) of three individual experiments. Two-way ANOVA with Dunnet´s post test was used to determine differences between argentatin A and B treatments compared with control (***p<0.0005).CC BY · PubMed Central
Fig 3 Percentage of LT CD4+ differentiated to Th1 and Th2 subtypes by argentatins. The treatment with both argentatins was at 50 μM and the differentiation process was evaluated by cytometry after 5 days of incubation. Error bars represent the standard error of the mean (SEM) of three individual experiment and the data can be found in S2 Table. Two-way ANOVA with Tukey´s post test was used to determine differences between argentatin A and B treatments compared with positive control (*p<0.05). No statistically significant differences were found with respect to the negative control.
Fig 3 Percentage of LT CD4+ differentiated to Th1 and Th2 subtypes by argentatins. The treatment with both argentatins was at 50 μM and the differentiation process was evaluated by cytometry after 5 days of incubation. Error bars represent the standard error of the mean (SEM) of three individual experiment and the data can be found in S2 Table. Two-way ANOVA with Tukey´s post test was used to determine differences between argentatin A and B treatments compared with positive control (*p<0.05). No statistically significant differences were found with respect to the negative control.CC BY · PubMed Central
Fig 4 Percentage of THP-1 macrophages differentiated to M1 and M2 subtypes by argentatins. The treatment with both argentatins was at 50 μM and the differentiation process was evaluated by cytometry after 3 days of incubation. Error bars represent the standard error of the mean (SEM) of three individual experiments and the data can be found in S2 Table. Two-way ANOVA with Tukey´s post test was used to determine differences between argentatin A and B treatments compared with controls. The letters refer to the significant difference compared to the negative control and the asterisk compared to the positive control (*p<0.05, **P<0.005, (a) P<0.05, (b) P<0.005).
Fig 4 Percentage of THP-1 macrophages differentiated to M1 and M2 subtypes by argentatins. The treatment with both argentatins was at 50 μM and the differentiation process was evaluated by cytometry after 3 days of incubation. Error bars represent the standard error of the mean (SEM) of three individual experiments and the data can be found in S2 Table. Two-way ANOVA with Tukey´s post test was used to determine differences between argentatin A and B treatments compared with controls. The letters refer to the significant difference compared to the negative control and the asterisk compared to the positive control (*p<0.05, **P<0.005, (a) P<0.05, (b) P<0.005).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 1

  1. M Martínez‐Vázquez, 1994, Antimicrobial properties of argentatin A, isolated from Parthenium argentatum, Fitoterapia, 65, 371

Cited by

Metadata

Authors
Silva-Nolasco, A. M., de la Cruz-Morcillo, M. A., García-Martínez, M. M., Zalacain, A., Gálvez, B. G., & Carmona, M.
Affiliations
  • Instituto Tecnico Agronómico Provincial (ES)
  • Universidad Complutense de Madrid (ES)
  • University of Castilla-La Mancha (ES)
Corresponding author
  • Gálvez, Beatriz G.
  • Carmona, Manuel
Venue
PLOS ONE
Published
2024-05-31
Volume
19
Issue
5
Pages
e0304713
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4399202345
Cited by
7
References
38
Citations by year
2026: 5 · 2025: 1 · 2024: 1
FWCI
1.70
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Universidad de Castilla-La Mancha and the European Social Fund (2022-UNIVERS-11373)
  • Universidad de Castilla-La Mancha and the European Social Fund Plus (2022-UNIVERS-11006)
  • Ministerio de Ciencia, Innovación y Universidades (Project PID2022-1424550B-100 by MCIN /AEI /10.13039/501100011033 / and by the European Regional Development Fund (ERDF).)
  • European Union-Next Generation EU through the Universidad de Castilla-La Mancha. (Margarita Salas (2022-NACIONA-11053))
Topics
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Phytochemistry and Biological Activities
  • Physical Sciences › Chemistry › Organic Chemistry › Sesquiterpenes and Asteraceae Studies
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant-Derived Bioactive Compounds
Keywords
Parthenium argentatum, guayule, immunomodulation, secondary metabolites, inflammatory cytokines, Th2 cells, M1 macrophages, CD4+ T cell polarization, macrophage polarization, autoimmune disease, allergic diseases, insect growth inhibitors
MeSH terms
Immunomodulating Agents, Humans, Immunologic Factors, Macrophages, CD4-Positive T-Lymphocytes, Cytokines, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.